ArticleRheumatology international2020

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease.

Chia Siang Kow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.